Ukoniq Side Effects Linked to Increased Risk of Death, FDA Warns, Withdraws Drug Approval
The risk of death from Ukoniq side effects results in the drug being removed from the market less than two years after receiving FDA approval.
The risk of death from Ukoniq side effects results in the drug being removed from the market less than two years after receiving FDA approval.
Similar problems, including an increased risk of death, have plagued other drugs from the same class in the past, the FDA warns.